Literature DB >> 24162256

Staphylococcus aureus genomic pattern and atopic dermatitis: may factors other than superantigens be involved?

A Rojo1, A Aguinaga, S Monecke, J R Yuste, G Gastaminza, A España.   

Abstract

The purpose of this investigation was to compare the genotypic profiles of Staphylococcus aureus isolated from atopic dermatitis (AD) patients and from control subjects, and to study the relationship between clinical severity, immune response, and genomic pattern of S. aureus isolated from AD patients. We selected 32 patients with AD and S. aureus skin colonization and 31 atopic controls with no history of AD who where asymptomatic carriers of S. aureus. Microarray-based genotyping was performed on S. aureus isolates. In AD patients, clinical severity was assessed using the Scoring Atopic Dermatitis index and total IgE levels and staphylococcal superantigen-specific IgE levels (SEA, SEB, SEC, TSST1) were determined. The genes lukE, lukD, splA, splB, ssl8, and sasG were more frequent in isolates from AD patients. CC30 was more common in isolates from atopic controls than in AD patients. There was a correlation between total IgE and clinical severity, but an association between clinical severity, immune response, and the presence of S. aureus superantigen genes, including enterotoxin genes, could not be demonstrated. Finally, a correlation was found between AD severity and other S. aureus genes, such as sasG and scn. S. aureus factors besides superantigens could be related to the worsening and onset of AD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24162256     DOI: 10.1007/s10096-013-2000-z

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  44 in total

1.  Prevalence of producers of enterotoxins and toxic shock syndrome toxin-1 among Staphylococcus aureus strains isolated from atopic dermatitis lesions.

Authors:  H Akiyama; Y Toi; H Kanzaki; J Tada; J Arata
Journal:  Arch Dermatol Res       Date:  1996-06       Impact factor: 3.017

2.  Serum IgE in atopic dermatitis: relationship to severity of cutaneous involvement and course of disease as well as coexistence of atopic respiratory diseases.

Authors:  B Wüthrich
Journal:  Clin Allergy       Date:  1978-05

3.  Genotypic and phenotypic characterization of Staphylococcus aureus strains isolated in subjects with atopic dermatitis. Higher prevalence of exfoliative B toxin production in lesional strains and correlation between the markers of disease intensity and colonization density.

Authors:  E Capoluongo; A Giglio A; M M Lavieri; I Lesnoni-La Parola; C Ferraro; A Cristaudo; M Belardi; F Leonetti; A Mastroianni; A Cambieri; P Amerio; F Ameglio
Journal:  J Dermatol Sci       Date:  2001-06       Impact factor: 4.563

4.  Colonization with superantigen-producing Staphylococcus aureus is associated with increased severity of atopic dermatitis.

Authors:  T M Zollner; T A Wichelhaus; A Hartung; C Von Mallinckrodt; T O Wagner; V Brade; R Kaufmann
Journal:  Clin Exp Allergy       Date:  2000-07       Impact factor: 5.018

5.  Comparison of serum specific IgE antibodies to staphylococcal enterotoxins between atopic children with and without atopic dermatitis.

Authors:  Y T Lin; W Y Shau; L F Wang; Y H Yang; Y W Hwang; M J Tsai; P N Tsao; B L Chiang
Journal:  Allergy       Date:  2000-07       Impact factor: 13.146

6.  Encoding a superantigen by Staphylococcus aureus does not affect clinical characteristics of infected atopic dermatitis lesions.

Authors:  A Kozman; Y Yao; P Bina; C Saha; W Yao; M H Kaplan; J B Travers
Journal:  Br J Dermatol       Date:  2010-12       Impact factor: 9.302

Review 7.  Practical issues on interpretation of scoring atopic dermatitis: the SCORAD index, objective SCORAD and the three-item severity score.

Authors:  A P Oranje; E J Glazenburg; A Wolkerstorfer; F B de Waard-van der Spek
Journal:  Br J Dermatol       Date:  2007-08-21       Impact factor: 9.302

8.  Clonal complexes and diversity of exotoxin gene profiles in methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from patients in a Spanish hospital.

Authors:  M A Argudín; M C Mendoza; F J Méndez; M C Martín; B Guerra; M R Rodicio
Journal:  J Clin Microbiol       Date:  2009-05-20       Impact factor: 5.948

9.  High prevalence of superantigens associated with the egc locus in Staphylococcus aureus isolates from patients with atopic eczema.

Authors:  M Mempel; G Lina; M Hojka; C Schnopp; H-P Seidl; T Schäfer; J Ring; F Vandenesch; D Abeck
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-05-13       Impact factor: 3.267

10.  Assignment of Staphylococcus aureus isolates to clonal complexes based on microarray analysis and pattern recognition.

Authors:  Stefan Monecke; Peter Slickers; Ralf Ehricht
Journal:  FEMS Immunol Med Microbiol       Date:  2008-05-27
View more
  9 in total

1.  Antimicrobial resistance investigation on Staphylococcus strains in a local hospital in Guangzhou, China, 2001-2010.

Authors:  Yang Deng; Junyan Liu; Brian M Peters; Lei Chen; Jian Miao; Bing Li; Lin Li; Dingqiang Chen; Guangchao Yu; Zhenbo Xu; Mark E Shirtliff
Journal:  Microb Drug Resist       Date:  2014-10-09       Impact factor: 3.431

2.  Clumping Factor B Promotes Adherence of Staphylococcus aureus to Corneocytes in Atopic Dermatitis.

Authors:  Orla M Fleury; Maeve A McAleer; Cécile Feuillie; Cécile Formosa-Dague; Emily Sansevere; Désirée E Bennett; Aisling M Towell; W H Irwin McLean; Sanja Kezic; D Ashley Robinson; Padraic G Fallon; Timothy J Foster; Yves F Dufrêne; Alan D Irvine; Joan A Geoghegan
Journal:  Infect Immun       Date:  2017-05-23       Impact factor: 3.441

3.  Regulation of Staphylococcal Superantigen-Like Gene, ssl8, Expression in Staphylococcus aureus strain, RN6390.

Authors:  Madhulatha Pantrangi; Vineet K Singh; Sanjay K Shukla
Journal:  Clin Med Res       Date:  2014-06-04

4.  High prevalence of methicillin resistance and PVL genes among Staphylococcus aureus isolates from the nares and skin lesions of pediatric patients with atopic dermatitis.

Authors:  F S Cavalcante; E D Abad; Y C Lyra; S B Saintive; M Ribeiro; D C Ferreira; K R N dos Santos
Journal:  Braz J Med Biol Res       Date:  2015-05-08       Impact factor: 2.590

5.  Staphylococcus Aureus Surface Protein G is An Immunodominant Protein and a Possible Target in An Anti-Biofilm Drug Development.

Authors:  Yury Belyi; Ivan Rybolovlev; Nikita Polyakov; Alena Chernikova; Irina Tabakova; Alexandre Gintsburg
Journal:  Open Microbiol J       Date:  2018-04-30

Review 6.  Staphylococcus aureus and the Cutaneous Microbiota Biofilms in the Pathogenesis of Atopic Dermatitis.

Authors:  Enea Gino Di Domenico; Ilaria Cavallo; Bruno Capitanio; Fiorentina Ascenzioni; Fulvia Pimpinelli; Aldo Morrone; Fabrizio Ensoli
Journal:  Microorganisms       Date:  2019-08-29

Review 7.  Colonization With Staphylococcus aureus in Atopic Dermatitis Patients: Attempts to Reveal the Unknown.

Authors:  Patrycja Ogonowska; Yolanda Gilaberte; Wioletta Barańska-Rybak; Joanna Nakonieczna
Journal:  Front Microbiol       Date:  2021-01-11       Impact factor: 5.640

8.  Methicillin-resistant Staphylococcus aureus from infected skin lesions present several virulence genes and are associated with the CC30 in Brazilian children with atopic dermatitis.

Authors:  Fernanda Sampaio Cavalcante; Simone Saintive; Dennis Carvalho Ferreira; Adriana Barbosa Rocha Silva; Lorrayne Cardoso Guimarães; Beatriz Stofel Braga; Eliane de Dios Abad; Marcia Ribeiro; Kátia Regina Netto Dos Santos
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

9.  Clonal Structure and Characterization of Staphylococcus aureus Strains from Invasive Infections in Paediatric Patients from South Poland: Association between Age, spa Types, Clonal Complexes, and Genetic Markers.

Authors:  Weronika M Ilczyszyn; Artur J Sabat; Viktoria Akkerboom; Anna Szkarlat; Joanna Klepacka; Iwona Sowa-Sierant; Barbara Wasik; Maja Kosecka-Strojek; Aneta Buda; Jacek Miedzobrodzki; Alexander W Friedrich
Journal:  PLoS One       Date:  2016-03-18       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.